When the patent for Claritin expired, the market experienced significant changes driven by the core characteristics of a monopoly: lack of competition, high prices, and barriers to entry.
What happens when patent-protected drugs lose exclusivity?
Before its patent expired, Claritin operated as a monopoly, meaning there was only one seller—Schering-Plough—in the market for the drug [1]. This lack of competition allowed the company to set prices without pressure from rivals and controlled the distribution of the medication. The patent served as a significant barrier to entry for other companies, preventing them from producing or selling generic versions of loratadine, the active ingredient in Claritin [2].
How did generic competition impact Claritin's market?
Following the expiration of Claritin's patent in 2002, the market opened to generic competition [2]. This influx of alternative, lower-cost loratadine products dramatically altered the market landscape. The presence of multiple manufacturers producing generic versions of the drug led to a sharp decrease in prices and a significant reduction in Schering-Plough's market share for loratadine [1][2].
What happened to Claritin's pricing after patent expiry?
The introduction of generic loratadine significantly lowered the price of the medication. Consumers and healthcare providers gained access to more affordable options, shifting purchasing patterns away from the brand-name Claritin. This price reduction is a direct consequence of the increased competition that arises once patent protection ends [1][2].
Can other companies make Claritin after the patent?
Yes, after the patent expired, other pharmaceutical companies became eligible to manufacture and sell generic versions of loratadine [2]. These companies do not need to invest in the extensive research and development that led to the original drug and can therefore offer their products at lower prices.
Where can I find information on drug patent expiry dates?
Information regarding drug patent expiry dates, including those for Claritin, can be found on specialized databases. DrugPatentWatch.com provides comprehensive data on pharmaceutical patents, offering insights into patent lifecycles and market exclusivity [3].
---
Sources:
1. https://drugpatentwatch.com/
2. https://drugpatentwatch.com/
3. https://drugpatentwatch.com/